Sponsor pipeline

Intra-Cellular Therapies, Inc. clinical trial pipeline

Get alerts when Intra-Cellular Therapies, Inc.'s trials change

11 active trials 10 recruiting 7 Phase 3 6 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-26
Completion pushed: 2027-03-23 → 2027-10-21
NCT06480383 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder · Phase 2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-08 NCT07807865 A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional… Phase 3 Recruiting

Active trials by phase

Phase 2
4
Phase 3
7

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07807865 A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional… Generalized Anxiety Disorder Recruiting 2026-09-29
NCT05850689 Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major… Major Depressive Disorder Recruiting 2026-09-25
NCT06229210 Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia… Schizophrenia Recruiting 2026-09-25
NCT06372964 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric… Bipolar Depression Recruiting 2026-09-25
NCT06690398 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With… Irritability Associated With Autism Spectrum Disorder Recruiting 2026-09-25
NCT06706674 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With… Irritability Associated With Autism Spectrum Disorder Recruiting 2026-09-25
NCT07747389 A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder Depressive Disorder, Major Not Yet Recruiting 2026-08-31
Phase 2
NCT06540833 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis… Psychotic Disorders Recruiting 2026-09-29
NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation… Agitation Associated With Alzheimer's Dementia Recruiting 2026-09-29
NCT06480383 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder Recruiting 2026-09-25
NCT06701903 Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder Recruiting 2026-09-25

Disease areas by active trials

Anxiety (3) · Depression (3) · Alzheimer's Disease (2) · Bipolar Disorder (2) · Dementia (1) · Schizophrenia (1)

Get alerts when Intra-Cellular Therapies, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free